Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection

MLA

Jenny Clarke, et al. “Streptolysin O Concentration and Activity Is Central to in Vivo Phenotype and Disease Outcome in Group A Streptococcus Infection.” Scientific Reports, vol. 11, no. 1, Sept. 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-021-97866-4.

APA

Jenny Clarke, Murielle Baltazar, Mansoor Alsahag, Stavros Panagiotou, Marion Pouget, William A. Paxton, Georgios Pollakis, Dean Everett, Neil French, & Aras Kadioglu. (2021). Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection. Scientific Reports, 11(1), 1–12. https://doi.org/10.1038/s41598-021-97866-4

Chicago

Jenny Clarke, Murielle Baltazar, Mansoor Alsahag, Stavros Panagiotou, Marion Pouget, William A. Paxton, Georgios Pollakis, Dean Everett, Neil French, and Aras Kadioglu. 2021. “Streptolysin O Concentration and Activity Is Central to in Vivo Phenotype and Disease Outcome in Group A Streptococcus Infection.” Scientific Reports 11 (1): 1–12. doi:10.1038/s41598-021-97866-4.